— Know what they know.
Not Investment Advice
Also trades as: DIA.MI (MIL) · $vol 19M

DSRLF OTC

DiaSorin S.p.A.
1W: -2.3% 1M: -2.3% 3M: +13.1% YTD: +10.5% 1Y: -10.9% 3Y: -5.3% 5Y: -56.0%
$84.00
-2.00 (-2.33%)
 
Weekly Expected Move ±1.2%
$82 $83 $84 $85 $86
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Neutral · Power 53 · $4.2B mcap · 21M float · 0.0006% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
$359M +15.1% ▲
5Y CAGR: +9.0%
Capital Expenditures
$120M -163.3% ▼
5Y CAGR: +16.5%
Free Cash Flow
$239M -10.2% ▼
5Y CAGR: +6.2%
Dividends Paid
$61M -3.9% ▼
Buybacks
$0 +100.0% ▲
Net Change in Cash
$64M +66.0% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income$248M$311M$240M$160M$187M
Depreciation & Amort.$61M$96M$153M$115M$129M
Stock-Based Comp.$7M$6M$10M$10M$11M
Change in Working Capital-$52M-$9M-$27M$4M$16M
Other Non-Cash Items$22M$29M-$9M$23M$16M
Operating Cash Flow$305M$401M$389M$312M$359M
— Investing Activities —
Capital Expenditures-$75M-$117M-$114M-$113M-$52M
Acquisitions (Net)$6M-$1.5B$21M$0$0
Investment Purchases-$1K$0-$140M$0$0
Investment Sales-$6M$0$118M$41M$0
Other Investing$2M$7M-$118M$44M$2M
Investing Cash Flow-$73M-$1.6B-$232M-$29M-$50M
— Financing Activities —
Net Debt Issuance-$8M$1.3B-$116M-$158M-$235M
Stock Repurchased-$26M-$9M-$160M-$19M$0
Dividends Paid-$52M-$55M-$57M-$59M-$61M
Other Financing$45M-$1K$0$0$0
Financing Cash Flow-$41M$1.3B-$333M-$236M-$259M
Net Change in Cash$182M$63M-$161M$39M$64M
Cash End of Period$340M$403M$242M$280M$344M
Free Cash Flow$230M$283M$276M$266M$239M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms